Home

Commission Implementing Regulation (EU) 2017/440 of 13 March 2017 concerning the authorisation of the preparation of Bacillus amyloliquefaciens (PTA-6507), Bacillus amyloliquefaciens (NRRL B-50013) and Bacillus amyloliquefaciens (NRRL B-50104) as a feed additive for chickens for fattening, chickens reared for laying, minor poultry species for fattening and minor poultry species reared for laying (holder of authorisation Danisco (UK) Ltd, trading as Danisco Animal Nutrition and represented by Genencor International B.V.) (Text with EEA relevance)Text with EEA relevance

Commission Implementing Regulation (EU) 2017/440 of 13 March 2017 concerning the authorisation of the preparation of Bacillus amyloliquefaciens (PTA-6507), Bacillus amyloliquefaciens (NRRL B-50013) and Bacillus amyloliquefaciens (NRRL B-50104) as a feed additive for chickens for fattening, chickens reared for laying, minor poultry species for fattening and minor poultry species reared for laying (holder of authorisation Danisco (UK) Ltd, trading as Danisco Animal Nutrition and represented by Genencor International B.V.) (Text with EEA relevance)Text with EEA relevance

Article 1

The preparation specified in the Annex, belonging to the additive category ‘zootechnical additives’ and to the functional group ‘gut flora stabilisers’, is authorised as an additive in animal nutrition, subject to the conditions laid down in that Annex.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

ANNEX

Identification number of the additive

Name of the holder of authorisation

Additive

Composition, chemical formula, description, analytical method

Species or category of animal

Maximum age

Minimum content

Maximum content

Other provisions

End of period of authorisation

CFU/kg of complete feedingstuff with a moisture content of 12 %

Category of zootechnical additives. Functional group: gut flora stabilisers

4b1827

Danisco (UK) Ltd, trading as Danisco Animal Nutrition and represented by Genencor International B.V.,

Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRL

B-50013 and Bacillus amyloliquefaciens NRRL B-50104

Additive composition

Preparation of Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRL

B-50013 and Bacillus amyloliquefaciens NRRL B-50104 containing a minimum of 2,5 × 109 CFU/g (total) with a minimum of bacterial concentration of 8,3 × 108 of each strain/g additive.

Solid form

Characterisation of the active substance

Viable spores of Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRL

B-50013 and Bacillus amyloliquefaciens NRRL B-50104

Analytical method(1)

Identification and enumeration of Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRL

B-50013 and Bacillus amyloliquefaciens NRRL B-50104 in the feed additive, premixtures and feedingstuffs

  • Identification: Pulsed Field Gel Electrophoresis (PFGE)

  • Enumeration: Spread plate method following heat treatment — EN 15784

Chickens for fattening

Chickens reared for laying

Minor poultry species for fattening and reared for laying

7,5 × 107

1. In the directions for use of the additive and premixture, indicate the storage temperature, storage life and stability to pelleting.

2. The use is compatible in feed containing the following authorised coccidiostats: narasin/nicarbazin, maduramicin ammonium, lasalocid A sodium, salinomycin sodium, monensin sodium, robenidine hydrochloride, diclazuril, decoquinate, semduramycin sodium or nicarbazin.

3. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from its use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment.

3 April 2027